"10.1371_journal.pmed.1001601","plos medicine","2014-02-11T00:00:00Z","Martin Gallagher; Alan Cass; Rinaldo Bellomo; Simon Finfer; David Gattas; Joanne Lee; Serigne Lo; Shay McGuinness; John Myburgh; Rachael Parke; Dorrilyn Rajbhandari; for the POST-RENAL Study Investigators and the ANZICS Clinical Trials Group","The George Institute for Global Health, Sydney, Australia; University of Sydney, Sydney, Australia; Menzies School of Health Research, Darwin, Australia; Austin Hospital, Heidelberg, Australia; Royal Prince Alfred Hospital, Camperdown, Australia; Auckland City Hospital, Auckland, New Zealand; St. George Clinical School, University of New South Wales, Sydney, Australia","Â¶ Membership of the POST-RENAL Study Investigators is provided in the Acknowledgments.","RB has received consulting fees from Gambro Pty Ltd. SF has received travel support to present research results at scientific meetings from Eli Lilly, Cardinal Health and CSL Bioplasma. The George Institute for Global Health, an independent not-for-profit institute affiliated with the University of Sydney, has received unrestricted grant support and travel expenses associated with a randomised-controlled trial of fluid resuscitation from Fresenius Kabi. It has also received reimbursement for SFs time as a steering committee member for studies sponsored by Eli Lilly and Eisai. The George Institute has received research funding from Servier, Novartis, Eisai, Merck, Sharp & Dohme, Pfizer Australia, Amgen, Fresenius Kabi Deutschland GmbH, and Sanofi Aventis.","2014","02","Martin Gallagher","MG",12,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
